Stephen S Gottlieb1, Kristie Harris2, John Todd3, Joel Estis3, Robert H Christenson4, Victoria Torres3, Kerry Whittaker5, Heather Rebuck4, Andrew Wawrzyniak5, David S Krantz5. 1. University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: sgottlie@medicine.umaryland.edu. 2. University of Maryland School of Medicine, Baltimore, MD, USA; Uniformed Services University of the Health Sciences, Bethesda, MD, USA. 3. Singulex Inc., Alameda, CA, USA. 4. University of Maryland School of Medicine, Baltimore, MD, USA. 5. Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Abstract
OBJECTIVES: Concentrations of endothelin I (ET1) are elevated in CHF patients and, like other biomarkers that reflect hemodynamic status and cardiac pathophysiology, are prognostic. The Singulex assay (Sgx-ET1) measures the active form of ET1, with a short in vivo half-life and the Brahms assay measures C-terminal endothelin-1 (CT-ET1), a modified (degraded) product with longer half-life. We aimed to determine the prognostic importance of active and modified forms of endothelin 1 (Singulex and Brahms assays) in comparison with other commonly measured biomarkers of inflammation, hemodynamic status and cardiac physiology in CHF. DESIGN AND METHODS: Plasma biomarkers (Sgx-ET1, CT-ET1, NTproBNP, IL-6, TNFα, cTnI, VEGF, hs-CRP, Galectin-3, ST2) were measured in 134 NYHA class II and III CHF patients with systolic dysfunction. Prognostic importance of biomarkers for hospitalization or death were calculated by both logistic regression and Kaplan-Meier survival analyses. RESULTS: CT-ET1 (OR=5.2, 95% CI=1.7-15.7) and Sgx-ET1 (OR=2.9, CI=1.1-7.7) were independent predictors of hospitalization and death and additively predicted events after adjusting for age, sex, and other significant biomarkers. Other biomarkers did not improve the model. Similarly, in Cox regression analysis, only CT-ET1 (HR 3.4, 95% CI=1.4-8.4), VEGF (2.7, 95% CI=1.3-5.4), and Sgx-ET1 (HR 2.6, 95% CI=1.2-5.6) were independently prognostic. CONCLUSIONS: Elevated concentrations of endothelin 1 predict mortality and hospitalizations in HF patients. Endothelin 1 was more prognostic than commonly obtained hemodynamic, inflammatory, and fibrotic biomarkers. Two different assays of endothelin 1 independently and synergistically were prognostic, suggesting either complementary information or extreme prognostic importance.
OBJECTIVES: Concentrations of endothelin I (ET1) are elevated in CHFpatients and, like other biomarkers that reflect hemodynamic status and cardiac pathophysiology, are prognostic. The Singulex assay (Sgx-ET1) measures the active form of ET1, with a short in vivo half-life and the Brahms assay measures C-terminal endothelin-1 (CT-ET1), a modified (degraded) product with longer half-life. We aimed to determine the prognostic importance of active and modified forms of endothelin 1 (Singulex and Brahms assays) in comparison with other commonly measured biomarkers of inflammation, hemodynamic status and cardiac physiology in CHF. DESIGN AND METHODS: Plasma biomarkers (Sgx-ET1, CT-ET1, NTproBNP, IL-6, TNFα, cTnI, VEGF, hs-CRP, Galectin-3, ST2) were measured in 134 NYHA class II and III CHFpatients with systolic dysfunction. Prognostic importance of biomarkers for hospitalization or death were calculated by both logistic regression and Kaplan-Meier survival analyses. RESULTS:CT-ET1 (OR=5.2, 95% CI=1.7-15.7) and Sgx-ET1 (OR=2.9, CI=1.1-7.7) were independent predictors of hospitalization and death and additively predicted events after adjusting for age, sex, and other significant biomarkers. Other biomarkers did not improve the model. Similarly, in Cox regression analysis, only CT-ET1 (HR 3.4, 95% CI=1.4-8.4), VEGF (2.7, 95% CI=1.3-5.4), and Sgx-ET1 (HR 2.6, 95% CI=1.2-5.6) were independently prognostic. CONCLUSIONS: Elevated concentrations of endothelin 1 predict mortality and hospitalizations in HF patients. Endothelin 1 was more prognostic than commonly obtained hemodynamic, inflammatory, and fibrotic biomarkers. Two different assays of endothelin 1 independently and synergistically were prognostic, suggesting either complementary information or extreme prognostic importance.
Authors: Ronald Van Beneden; Olivier Gurné; Philippe L Selvais; Sylvie A Ahn; Annie R Robert; Jean-Marie Ketelslegers; Hubert G Pouleur; Michel F Rousseau Journal: J Card Fail Date: 2004-12 Impact factor: 5.712
Authors: F Pousset; F Masson; O Chavirovskaia; R Isnard; A Carayon; J L Golmard; P Lechat; D Thomas; M Komajda Journal: Eur Heart J Date: 2000-06 Impact factor: 29.983
Authors: Stephanie Neuhold; Martin Huelsmann; Guido Strunk; Joachim Struck; Christopher Adlbrecht; Ghazaleh Gouya; Marie Elhenicky; Richard Pacher Journal: Clin Chem Date: 2009-11-02 Impact factor: 8.327
Authors: Benjamin Dieplinger; Alfons Gegenhuber; Joachim Struck; Werner Poelz; Werner Langsteger; Meinhard Haltmayer; Thomas Mueller Journal: Clin Chim Acta Date: 2008-10-29 Impact factor: 3.786
Authors: Kristie M Harris; David S Krantz; Willem J Kop; Joanne Marshall; Shawn W Robinson; Jennifer M Marshall; Stephen S Gottlieb Journal: JACC Heart Fail Date: 2017-05-10 Impact factor: 12.035
Authors: Hanghang Wang; Kevin Anstrom; Olga Ilkayeva; Michael J Muehlbauer; James R Bain; Steven McNulty; Christopher B Newgard; William E Kraus; Adrian Hernandez; G Michael Felker; Margaret Redfield; Svati H Shah Journal: JAMA Cardiol Date: 2017-08-01 Impact factor: 14.676
Authors: Benjamin S Frank; Tracy T Urban; Karlise Lewis; Suhong Tong; Courtney Cassidy; Max B Mitchell; Christopher S Nichols; Jesse A Davidson Journal: Congenit Heart Dis Date: 2019-01-16 Impact factor: 2.007
Authors: Peter J Leary; Nancy S Jenny; David A Bluemke; Steven M Kawut; Richard A Kronmal; Joao A Lima; Bradley A Maron; David D Ralph; Samuel G Rayner; John J Ryan; Zachary L Steinberg; Karen D Hinckley Stukovsky; Ryan J Tedford Journal: J Heart Lung Transplant Date: 2019-08-10 Impact factor: 10.247
Authors: Jacob C Monroe; Chen Lin; Susan M Perkins; Yan Han; Brett J Wong; Raghu L Motaganahalli; Bruno T Roseguini Journal: J Appl Physiol (1985) Date: 2020-10-01